Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.

Atherosclerosis. Supplements

Volumn 5, Issue 3, 2004, Pages 115-123

  Shepherd, James ^a   Hunninghake, Donald B ^a   Barter, Philip ^a   McKenney, James M ^a   Hutchinson, Howard G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; FLUOROBENZENE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PRAVASTATIN; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; ROSUVASTATIN; SIMVASTATIN; SULFONAMIDE;

ARTICLE; BLOOD; CORONARY ARTERY DISEASE; HISTORY; HUMAN; MOTIVATION; PRACTICE GUIDELINE; RISK FACTOR;

ANTILIPEMIC AGENTS; CORONARY DISEASE; FLUOROBENZENES; GOALS; HEPTANOIC ACIDS; HISTORY, 20TH CENTURY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; PRACTICE GUIDELINES; PRAVASTATIN; PYRIMIDINES; PYRROLES; RISK FACTORS; SIMVASTATIN; SULFONAMIDES;

EID: 16644401750     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2004.08.032     Document Type: Article

References (0)